Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-24T05:05:18.675Z Has data issue: false hasContentIssue false
  • English
  • Français

Anticholinesterase Drugs and Epileptic Seizures

Published online by Cambridge University Press:  29 January 2018

Stoyan Ikonomoff
Stoyan Ikonomoff*
Affiliation:
Formerly at Plovdiv Hospital, Plovdiv, Bulgaria
Get access Rights & Permissions [Opens in a new window]

Extract

Despite the views of many authors that migraine and epilepsy are unrelated phenomena, there is much evidence to the contrary. Davidenkov (1934) studied fifty parents with epilepsy, twenty-six of whose children had migraine. Barolin (1966) and Janzen (1969) also present evidence of a high incidence of migraine in epileptics. Owing to the success in treating migraine with anticholinesterases syntostigmin and nivalin (Ikonomoff, 1961, 1967, 1968), and the possible relationship between migraine and epilepsy, the same anticholinesterase drugs were administered to epileptics. Tentative and careful studies with syntostigmin and nivalin seemed to show that these anticholinesterases could be given with safety and apparent success. A study was therefore. undertaken of the effects of syntostigmin.

Type
Abstract
Information
The British Journal of Psychiatry , Volume 117 , Issue 541 , December 1970 , pp. 679 - 680
Copyright
Copyright © The Royal College of Psychiatrists, 1970 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barolin, G. S. (1966). ‘Migraines and epilepsies—a relationship?’ Epilepsia, 7, 53–66.Google Scholar
Bradley, P. B., and Elkes, J. (1957). ‘The effects of some drugs on the electrical activity of the brain.’ Brain, 80, 77–117.Google Scholar
Celesia, G. G., and Jasper, H. H. (1966). ‘Acetylcholine released from cerebral cortex in relation to state of activation.’ Neurology, Minneapolis, vol. 16, No. 11.Google ScholarPubMed
Davidenkov, S. N. (1961). Clinical Lectures on Nervous Diseases. Vol. IV, Leningrad, Medgiz.Google Scholar
Ikonomoff, St. Iv. (1961). ‘Treatment of migraine with nivalin.’ Fourth National Conference of Neurologists and Psychiatrists, Sofia.Google Scholar
Ikonomoff, St. Iv. (1967). ‘Cerebrocardiac form of migraine.’—Headacne, April.Google Scholar
Ikonomoff, St. Iv. (1968) ‘Nouvelle méthode de traitement de la migraine au moyen de médicaments anticholinestérasiques.’ Archives Suisses de Neurologic, Neurochirurgie et Psychiatric, Vol. 102, Fascicule 2, pp. 299–312.Google Scholar
Janzen, R. (1969). ‘Epileptische Anfälle Migräne als Beispiele für polygenetische terminale Reaktionsformen des Nervensystems.’ Materia Medica Nordmark, XXI, 1–8.Google Scholar
Kreindler, A. (1954). Epilepsia, Bucarest.Google Scholar
Mazars, Y., Mazars, G., and Piot, Cl. (1966). ‘Action favorable de la prostigmine dans certains cas d'épilepsie centrencéphaliques.’ Revue Neurologique, Paris, 114, No. 3, 214–5.Google Scholar
Zakusov, V. V. (1960). Pharmacology. Medgiz.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.